Skip to content
Open access

In silico prediction and structural profiling of human CYP2E1 missense variants implicated in hepatotoxic injuries

Aug 2026 · Journal of Genetic Engineering and Biotechnology · Vol 24, pp. 100799 · 0 citations · 37 references

TL;DR

A structure-aware in silico pipeline to prioritize and mechanistically profile human CYP2E1 nsSNPs is developed and mechanistic hypotheses linking coding substitutions to altered heme positioning and potential increases in ROS leakage are provided.

Abstract

CYP2E1 sits at the crossroads of xenobiotic metabolism and oxidative-stress generation, yet the functional consequences of most coding variants are unknown. We developed a structure-aware in silico pipeline to prioritize and mechanistically profile human CYP2E1 nsSNPs. From 490 missense SNPs collected, a consensus cascade of 27 prediction tools and evolutionary conservation filters yielded 24 high-confidence candidates, six highly conserved substitutions were subjected to all-atom MD. Trajectories analysis revealed variant-specific atomistic phenotypes spanning core collapse, access-tunnel rigidification, and localized electrostatic destabilization. G300R produced the largest structural disruption, while R359P induced pronounced rigidification of access-region dynamics, both emerged as top candidates for altered coupling efficiency and hepatotoxic risk. We provided a ranked variant list and mechanistic hypotheses linking coding substitutions to altered heme positioning and potential increases in ROS leakage. This structure-based prioritization framework is intended to guide experimental biochemical, cellular and pharmacogenetic follow-up in studies of drug-induced and chronic liver injury.

Read PDF

Similar papers

Open access Aug 2026

In Silico Prioritization of Variants of Uncertain Significance in ABCA4 Reveals Conserved Functional Motifs

This integrative computational framework identifies four conserved motifs likely critical to ECD2 and ABCA4 function, and yields a prioritized, mechanistically grounded list of ECD2 variants for targeted experimental validation.

Jazzlyn S. Jones, Barry Bodt, Subhasis B. Biswas et al. · 0 citations
Open access Aug 2026

Integrated In Silico Discovery of Thymoquinone Analogs Targeting the Keap1–Nrf2 Pathway for Amyotrophic Lateral Sclerosis Therapy

This study identifies structurally tractable TQ analogs with improved predicted potency and establishes a robust computational framework for neuroprotective discovery as redox‐modulating agents in ALS.

Jabir C Nalicho, P. Mabeyo, Andrew S. Paluch et al. · 0 citations
Open access Sep 2026

Network pharmacology and in silico validation of sesamin targeting AR and MAPK1 in COVID-19 and malaria

Introduction: COVID-19 and malaria may coexist in endemic regions, creating diagnostic and therapeutic challenges, while evidence-based strategies addressing their co-occurrence remain limited. Objective: This study evaluates sesamin, a natural compound with reported antiviral, antioxidant, anti-inflammatory, and immun...

Mst. Tania Khatun, Md Arju Hossain, M. Hasan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.